title: A priming effect of naloxone on in vitro LHRH release from the hypothalamus of mid-luteal ewes.
abstract: The possible involvement of endogenous opioid peptides (EOPs) in LHRH release from hypothalami of ewes during the breeding season was investigated using an in vitro perifusion system. Hypothalami were procured in December from ovariectomized (OVX; 62-65 days before the experiment; n = 6) and mid-luteal (ML; n = 7) Western White-Face ewes. Hypothalami were mid-sagitally sectioned into halves containing the preoptic area, mediobasal hypothalamus, and infundibulum (median eminence). The left half (treated) received two 30-min challenges (beginning at 130 and 250 min, respectively, after onset of perifusion) of 500 microM naloxone (NAL) followed by a 30-min 60-mM potassium (K) challenge (at 370 min after onset of perifusion). The right half served as the control, receiving only K at the same time as the treated tissue. Both NAL challenges elicited (p less than 0.05) LHRH release from tissues of both ML and OVX ewes. Release of LHRH by hypothalami from ML, but not from OVX, ewes was greater (p less than 0.01) after the second than after the first NAL challenge. These results are consistent with the view that an inhibitory opioid influence exists on LHRH release from ovine hypothalami. The release of LHRH in response to NAL was dependent on the ovarian status in vivo since the priming effect of NAL on subsequent NAL-induced LHRH release occurred only from the hypothalami of ML ewes. We suggest from these results that EOPs may modulate LHRH release from ovine hypothalami in an ovarian steroid-dependent and independent manner.
authors.affiliation: Department of Animal Science, Texas A&M University, College Station 77843.
authors.forename: T J
authors.initials: TJ
authors.lastname: Wu
authors.forename: D L
authors.initials: DL
authors.lastname: Morris
authors.forename: N H
authors.initials: NH
authors.lastname: McArthur
authors.forename: P G
authors.initials: PG
authors.lastname: Harms
mesh_terms: D000818:Animals; D004723:Endorphins / Q000502:physiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D066298:In Vitro Techniques; D008183:Luteal Phase / Q000187:drug effects / Q000502:physiology*; D009270:Naloxone / Q000494:pharmacology; D010052:Ovariectomy; D010477:Perfusion; D012756:Sheep
chemical_list: D004723:Endorphins; D007987:Gonadotropin-Releasing Hormone; D009270:Naloxone